drug
prasterone
Marketedupdated 5mo agoby Cosette Pharmaceuticals Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying prasterone
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 7, 2028
~1.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Mar 19, 2031formulationUS 82688064.5y
- Jan 8, 2030method-of-use (U-1922)US 89570543.3y
- Aug 7, 2028formulationUS 86291291.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that